Saturday, November 6, 2021
- 8:30AM-10:30AM
-
Abstract Number: 0177
Dual-Energy Computed Tomography Three Material Decomposition Improves the Sensitivity of Gout Detection
Imaging of Rheumatic Diseases Poster (0149–0182)- 8:30AM-10:30AM
-
Abstract Number: 0153
Echogenic and Hypervascular Synovium Detected on Ultrasound Are Predictive of a Favorable Response After Intra-articular Corticosteroid Injection in Patients with Knee Osteoarthritis
Imaging of Rheumatic Diseases Poster (0149–0182)- 8:30AM-10:30AM
-
Abstract Number: 0143
Economic and Healthcare Resource Use Burden of Systemic Sclerosis
Health Services Research Poster I: Lupus, Inflammatory Arthritis, & More (0128–0148)- 8:30AM-10:30AM
-
Abstract Number: 0240
Economic Burden of Fatigue Among Patients with Psoriatic Arthritis – a Retrospective Study Using Claims Data, 2009-2019
Patient Outcomes, Preferences, & Attitudes Poster I: Impact (0225–0240)- 8:30AM-10:30AM
-
Abstract Number: 0058
Effect of Anti-inflammatory Drugs on Intestinal Epithelial Damage and Bacterial Translocation in the Adjuvant-induced Arthritis Model
Spondyloarthritis Including PsA – Basic Science Poster (0046–0068)- 8:30AM-10:30AM
-
Abstract Number: 0268
Effect of Biologic Agents on Lipids and Cardiovascular Risk in Rheumatoid Arthritis Patients
RA – Diagnosis, Manifestations, & Outcomes Poster I: Cardiovascular Pulmonary Disease (0268–0295)- 8:30AM-10:30AM
-
Abstract Number: 0414
Effect of Induction Therapies on Ear, Nose and Throat Involvement in Anti-neutrophil Cytoplasmic Antibody Associated Vasculitis: Results from a Multi-center Cohort Study
Vasculitis – ANCA-Associated Poster (0414–0436)- 8:30AM-10:30AM
-
Abstract Number: 0188
Effect of Nintedanib on Categorical Changes in FVC in Patients with Progressive Fibrosing ILDs: Further Analyses of the INBUILD Trial
Miscellaneous Rheumatic & Inflammatory Diseases Poster I (0183–0209)- 8:30AM-10:30AM
-
Abstract Number: 0403
Effect of Nintedanib on KL-6 in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
Systemic Sclerosis & Related Disorders – Clinical Poster I (0387–0413)- 8:30AM-10:30AM
-
Abstract Number: 0243
Effectiveness of Abatacept in Patients with JIA, Classified by Category: Results from the PRCSG/PRINTO JIA Real-World Registry
Pediatric Rheumatology – Clinical Poster I: JIA (0241–0265)- 8:30AM-10:30AM
-
Abstract Number: 0224
Effects of Kinesiophobia and Physical Function on Physical Activity in Adults with Knee Osteoarthritis
Osteoarthritis – Clinical Poster I (0210–0224)- 8:30AM-10:30AM
-
Abstract Number: 0222
Effects of Multi-Joint Osteoarthritis Phenotypes on Self-Reported Physical Function over 3.5 Years: The Johnston County Osteoarthritis Project
Osteoarthritis – Clinical Poster I (0210–0224)- 8:30AM-10:30AM
-
Abstract Number: 0183
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 24-Week Results from the Phase 3, Randomized, Double-blind Clinical Trial for CsDMARD-IR and Bio-IR Patients
Miscellaneous Rheumatic & Inflammatory Diseases Poster I (0183–0209)- 8:30AM-10:30AM
-
Abstract Number: 0108
Efficacy of SARS-CoV-2 Vaccine in Patients with Rheumatic Diseases: A Systematic Review and Meta-Analysis